The company's platform relies on a method called RABID-seq that combines barcoded viral tracing with single-cell RNA-seq to study interactions between brain cells.

The application was based on results from a Phase I/II trial in which Hyrnuo demonstrated a 71 percent response rate.

Investigators will analyze CTCs from colon, gastrointestinal, and lung cancer patients to help understand how they respond to exercise regimens.

Investigators will analyze CTCs from colon, gastrointestinal, and lung cancer patients to help understand how they respond to exercise regimens.

The approval is for DEB patients from birth and allows for flexible administration at home by patients or caregivers.

The principal investigator reported at the ASGCT meeting that the study met its primary endpoint, though there were two treatment-related serious adverse events.

The agency approved the antibody-drug conjugate for treating HER2-positive neoadjuvant and adjuvant breast cancer alongside an IHC and an ISH test for identifying best responders.

Sponsor Benitec anticipates formalizing its plan for a pivotal trial of BB-301 with the US Food and Drug Administration in mid-2026.

The firm said the preclinical data supports studying its lead candidate SIL-204 in combination with immunotherapy in KRAS-mutant pancreatic cancer.

The partners will incorporate Telix's PSMA-PET gallium 68-based imaging agents Gozellix and Illuccix with EDAP and Profound's technologies for minimally invasive treatment.

The CELIA trial didn't meet its main goal of assessing dose response for change from baseline on a clinical dementia scale, but the ASO diranersen did lower tau levels and slow clinical decline.

On CGTxchange, sponsors can list their shelved cell and gene therapies in the hopes that other investors, partners, and ...